Two Sigma Advisers’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,300
Closed -$1.31M 2576
2023
Q1
$1.31M Sell
18,300
-14,200
-44% -$1.13M ﹤0.01% 1489
2022
Q4
$2.29M Sell
32,500
-7,800
-19% -$550K 0.01% 1170
2022
Q3
$2.44M Buy
40,300
+7,100
+21% +$476K 0.01% 1070
2022
Q2
$2.1M Sell
33,200
-15,700
-32% -$1.02M 0.01% 1188
2022
Q1
$3.13M Buy
48,900
+26,500
+118% +$1.77M 0.01% 1021
2021
Q4
$1.61M Sell
22,400
-42,200
-65% -$3.21M ﹤0.01% 1301
2021
Q3
$4.61M Sell
64,600
-49,200
-43% -$3.88M 0.01% 823
2021
Q2
$9.26M Sell
113,800
-17,200
-13% -$1.38M 0.02% 601
2021
Q1
$9.89M Sell
131,000
-15,500
-11% -$1.13M 0.03% 580
2020
Q4
$11.1M Sell
146,500
-79,200
-35% -$5.16M 0.03% 534
2020
Q3
$11.2M Sell
225,700
-54,300
-19% -$3.06M 0.03% 502
2020
Q2
$14.7M Sell
280,000
-9,000
-3% -$427K 0.04% 409
2020
Q1
$10.2M Buy
289,000
+286,196
+10,207% +$16.7M 0.04% 478
2019
Q4
$245K Sell
2,804
-6,100
-69% -$533K ﹤0.01% 2123
2019
Q3
$755K Sell
8,904
-17,500
-66% -$1.56M ﹤0.01% 1553
2019
Q2
$2.78M Sell
26,404
-25,500
-49% -$2.56M 0.01% 1066
2019
Q1
$5.48M Buy
51,904
+3,100
+6% +$311K 0.01% 810
2018
Q4
$4.08M Sell
48,804
-44,009
-47% -$3.99M 0.01% 875
2018
Q3
$9.46M Sell
92,813
-37,200
-29% -$3.59M 0.02% 602
2018
Q2
$10.5M Sell
130,013
-61,900
-32% -$4.92M 0.03% 574
2018
Q1
$14.1M Buy
191,913
+24,962
+15% +$1.87M 0.04% 474
2017
Q4
$11.8M Buy
166,951
+35,900
+27% +$2.59M 0.03% 545
2017
Q3
$8.19M Sell
131,051
-12,662
-9% -$750K 0.02% 630
2017
Q2
$8.25M Buy
143,713
+5,800
+4% +$341K 0.03% 572
2017
Q1
$8.39M Buy
137,913
+41,436
+43% +$2.34M 0.03% 625
2016
Q4
$5.29M Buy
96,477
+21,876
+29% +$1.05M 0.02% 713
2016
Q3
$3.44M Buy
74,601
+53,401
+252% +$2.25M 0.01% 798
2016
Q2
$722K Buy
+21,200
New +$662K ﹤0.01% 1336

Other funds holding NGVT

Two Sigma Advisers's NGVT Position: Q2 2023 in Review

Two Sigma Advisers sold out of Ingevity (NGVT) in Q2 2023, closing a stake of 18,300 shares — an estimated $1.31M sold.

Two Sigma Advisers first reported a position in NGVT in Q2 2016 and held it in 28 quarters. The position peaked at $14.7M in Q2 2020. 251 funds tracked by Wall St. Rank hold NGVT as of Q2 2023.

  • Two Sigma Advisers reported no remaining Ingevity position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 18,300 Ingevity shares in Q2 2023, an estimated $1.31M.
  • Two Sigma Advisers first reported a position in Ingevity in Q2 2016 and held it in 28 quarters.
  • Two Sigma Advisers's Ingevity position peaked at $14.7M in Q2 2020.
  • 251 funds tracked by Wall St. Rank held Ingevity as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.